Hyam I. Levitsky's Insider Trades & SAST Disclosures
Hyam I. Levitsky's most recent trade in Replimune Group Inc was a trade of 32,000 Stock Option (right to buy) done . Disclosure was reported to the exchange on April 1, 2024.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Hyam I. Levitsky.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Replimune Group Inc | Hyam I. Levitsky | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2024 | 32,000 | 32,000 | - | - | Stock Option (right to buy) | |
| Century Therapeutics Inc | Hyam I. Levitsky | President of R&D | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Mar 2024 | 146,000 | 146,000 | - | - | Stock Option (right to buy) | |
| Century Therapeutics Inc | Hyam I. Levitsky | President of R&D | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Mar 2024 | 24,000 | 24,000 | - | 0 | Common Stock | |
| Replimune Group Inc | Hyam I. Levitsky | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2023 | 25,200 | 25,200 | - | - | Stock Option (right to buy) | |
| Replimune Group Inc | Hyam I. Levitsky | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2022 | 16,500 | 16,500 | - | - | Stock Option (right to buy) | |
| Century Therapeutics Inc | Hyam I. Levitsky | President of R&D | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2022 | 105,000 | 105,000 | - | - | Stock Option (right to buy) | |
| Replimune Group Inc | Hyam I. Levitsky | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2021 | 16,500 | 16,500 | - | - | Stock Option (right to buy) |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges